Red ear syndrome: a case series and review of the literature.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
09 Jul 2024
Historique:
received: 31 07 2023
accepted: 01 03 2024
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

Red Ear Syndrome is a burning sensation and erythema of the ear, associated with a various number of disorders including migraine, trigeminal neuralgia, autoimmune disorders etc. Theories for RES pathophysiology have developed from current understandings of comorbid conditions. Characterizing the underlying mechanism of RES is crucial for defining effective treatments. Three caucasian patients, ages 15, 47, and 67 years, with migraine, one with erythromelalgia are reported in this manuscript. RES pathophysiology is not fully understood due to its variable clinical presentation and numerous comorbid conditions, making it difficult to identify effective treatments. RES seems to be largely treatment-resistant, and most options involve treating the associated disorders and minimizing pain. Further investigation of future cases should lead to a more comprehensive understanding of the fundamental cause of RES and, hopefully, successful treatments.

Sections du résumé

BACKGROUND BACKGROUND
Red Ear Syndrome is a burning sensation and erythema of the ear, associated with a various number of disorders including migraine, trigeminal neuralgia, autoimmune disorders etc. Theories for RES pathophysiology have developed from current understandings of comorbid conditions. Characterizing the underlying mechanism of RES is crucial for defining effective treatments.
CASE PRESENTATION METHODS
Three caucasian patients, ages 15, 47, and 67 years, with migraine, one with erythromelalgia are reported in this manuscript. RES pathophysiology is not fully understood due to its variable clinical presentation and numerous comorbid conditions, making it difficult to identify effective treatments.
CONCLUSION CONCLUSIONS
RES seems to be largely treatment-resistant, and most options involve treating the associated disorders and minimizing pain. Further investigation of future cases should lead to a more comprehensive understanding of the fundamental cause of RES and, hopefully, successful treatments.

Identifiants

pubmed: 38978093
doi: 10.1186/s13256-024-04485-4
pii: 10.1186/s13256-024-04485-4
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

327

Informations de copyright

© 2024. The Author(s).

Références

Lance JW. The red ear syndrome. Neurology. 1996;47(3):617–20. https://doi.org/10.1212/wnl.47.3.617 .
doi: 10.1212/wnl.47.3.617 pubmed: 8797453
Lambru G, Miller S, Matharu MS. The red ear syndrome. J Headache Pain. 2013;14(1):83. https://doi.org/10.1186/1129-2377-14-83 .
doi: 10.1186/1129-2377-14-83 pubmed: 24093332 pmcid: 3850925
D’Amico A, Galati C, Manzo M, et al. Red ear syndrome in children: review of literature and report of three cases. Int J Pediatric Otorhinolaryngol. 2021;142:110615.
doi: 10.1016/j.ijporl.2021.110615
Raieli V, Compagno A, Brighina F, et al. Prevalence of red ear syndrome in juvenile primary headaches. Cephalalgia. 2011;31(5):597–602. https://doi.org/10.1177/0333102410388437 .
doi: 10.1177/0333102410388437 pubmed: 21123628
Al-Din A, Mir R, Davey R, et al. Trigeminal cephalgias and facial pain syndromes associated with autonomic dysfunction. Cephalalgia: Sage Journals; 2005.
doi: 10.1111/j.1468-2982.2005.00935.x
Callan G, Tolebeyan A. Botulinum toxin: treatment for refractory chronic migraine and red ear syndrome. Ann Headache Med. 2023.
Boulton P, Purdy RA, Bosch EP, et al. Primary and secondary red ear syndrome: implications for treatment. Cephalalgia. 2007;27(2):107–10. https://doi.org/10.1111/j.1468-2982.2007.01270.x .
doi: 10.1111/j.1468-2982.2007.01270.x pubmed: 17257229
Kaneda S, Goto F, Teramura T, et al. Red ear syndrome presenting with vestibular migraine: case study and review of the literature. J Laryngol Otol. 2022;136(12):1330–2. https://doi.org/10.1017/s002221512100311x .
doi: 10.1017/s002221512100311x pubmed: 34674783
Uca AU, Kozak HH. Coexistence of migraine headache and red ear syndrome. Noro Psikiyatr Ars. 2014;51(3):294. https://doi.org/10.4274/npa.y7619 .
doi: 10.4274/npa.y7619 pubmed: 28360643 pmcid: 5353140
Chan CC, Ghosh S. Red ear syndrome precipitated by a dietary trigger: a case report. J Med Case Rep. 2014;8:338. https://doi.org/10.1186/1752-1947-8-338 .
doi: 10.1186/1752-1947-8-338 pubmed: 25303997 pmcid: 4196464
Raieli V, Compagno A, D’Amelio M. Red ear syndrome. Curr Pain Headache Rep. 2016;20(3):19. https://doi.org/10.1007/s11916-016-0547-y .
doi: 10.1007/s11916-016-0547-y pubmed: 26879877
Peretz AM, Woldeamanuel YW, Rapoport AM, et al. Spontaneous extracranial hemorrhagic phenomena in primary headache disorders: a systematic review of published cases. Cephalalgia. 2016;36(13):1257–67. https://doi.org/10.1177/0333102415618951 .
doi: 10.1177/0333102415618951 pubmed: 26611681
Donnet A, Valade D. The red ear syndrome. J Neurol Neurosurg Psychiatry. 2004;75:1077.
doi: 10.1136/jnnp.2003.030742 pubmed: 15201382 pmcid: 1739123
Patel I, Desai D, Desai S. Red ear syndrome: case series and review of a less recognized headache disorder. Ann Indian Acad Neurol. 2020;23(5):715–8. https://doi.org/10.4103/aian.AIAN_1_20 .
doi: 10.4103/aian.AIAN_1_20 pubmed: 33623284 pmcid: 7887477
de Amorim IL, Kauppila LA, Martins IP. Red ear: syndrome or symptom? Headache. 2018;58(6):885–91. https://doi.org/10.1111/head.13333 .
doi: 10.1111/head.13333 pubmed: 29802637
Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019;44(5):477–82. https://doi.org/10.1111/ced.13891 .
doi: 10.1111/ced.13891 pubmed: 30609105

Auteurs

Grace M Callan (GM)

Medical College of Wisconsin, Milwaukee, USA.

Frederick Freitag (F)

Medical College of Wisconsin, Milwaukee, USA.

Amir Soheil Tolebeyan (AS)

Tufts Medical Center, Tufts University School of Medicine, Boston, USA. amir.tolebeyan@tuftsmedicine.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH